Klaus Herfarth
Overview
Explore the profile of Klaus Herfarth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
2130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoffmeister-Wittmann P, Hoegen-Sassmannshausen P, Wicklein L, Weykamp F, Seidensaal K, Springfeld C, et al.
Radiat Oncol
. 2025 Feb;
20(1):23.
PMID: 39966902
Background And Aims: Liver cancer is the third leading cause of cancer related death due to treatment resistance and late onset of symptoms (Rumgay in J Hepatol 77: 1598-1606, 2022)....
2.
Wark A, Kim J, Mavriopoulou E, Fougere C, Wiegel T, Scholz C, et al.
Strahlenther Onkol
. 2025 Jan;
PMID: 39808202
Purpose: Recent advancements in imaging, particularly 18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT), have improved the detection of involved lymph nodes, thus influencing staging accuracy and potentially treatment outcomes. This study is...
3.
Bauer L, Paul A, Regnery S, Deng M, Ellerbrock M, Mielke T, et al.
Front Oncol
. 2024 Dec;
14:1437412.
PMID: 39650062
Introduction: Due to the rarity of mucosal melanomas, few recent studies can be found investigating the success and side effects of therapy for this entity with large numbers of patients....
4.
Deng M, Rauh S, Anil G, Lischalk J, Hahnemann L, Eichkorn T, et al.
Neurooncol Adv
. 2024 Oct;
6(1):vdae160.
PMID: 39434923
Background: Primary optic nerve sheath meningiomas (ONSMs) represent a group of benign tumors originating from the optic nerve sheath, typically causing painless, gradual onset monocular visual loss, which can result...
5.
Weykamp F, Schaub L, Eichhorn M, Winter H, Schirmacher P, Thomas M, et al.
Adv Radiat Oncol
. 2024 Sep;
9(9):101573.
PMID: 39234234
Purpose: Superior sulcus tumors are frequently treated with neoadjuvant chemoradiation therapy (nCRT) followed by surgery via a trimodal approach. The INKA study evaluated the replacement of photon irradiation by carbon...
6.
Janke F, Stritzke F, Dvornikovich K, Franke H, Angeles A, Riediger A, et al.
Int J Cancer
. 2024 Aug;
156(4):853-864.
PMID: 39212345
Local recurrence after radiotherapy is common in locally advanced head and neck cancer (HNC) patients. Re-irradiation can improve local disease control, but disease progression remains frequent. Hence, predictive biomarkers are...
7.
Seidensaal K, Froehlke A, Lentz-Hommertgen A, Lehner B, Geisbuesch A, Meis J, et al.
Radiother Oncol
. 2024 Jun;
198:110418.
PMID: 38944346
Introduction: Sacrococcygeal chordomas have high recurrence rates and are challenging to treat. Methods: In this phase II prospective, randomized, stratified trial, the safety and feasibility of hypofractionated ion radiation therapy...
8.
Hoeltgen L, Meixner E, Hoegen-Sassmannshausen P, Kim J, Deng M, Seidensaal K, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893114
Helium ion therapy (HRT) is a promising modality for the treatment of pediatric tumors and those located close to critical structures due to the favorable biophysical properties of helium ions....
9.
Wark A, Gupta A, Meixner E, Konig L, Horner-Rieber J, Forster T, et al.
Technol Cancer Res Treat
. 2024 Jun;
23:15330338241252622.
PMID: 38845139
The aim of this matched-pair cohort study was to evaluate the potential of intensity-modulated proton therapy (IMPT) for sparring of the pelvic bone marrow and thus reduction of hematotoxicity compared...
10.
Hoegen-Sassmannshausen P, Naumann P, Hoffmeister-Wittmann P, Harrabi S, Seidensaal K, Weykamp F, et al.
JHEP Rep
. 2024 May;
6(6):101063.
PMID: 38737600
Background & Aims: Inoperable hepatocellular carcinoma (HCC) can be treated by stereotactic body radiotherapy. However, carbon ion radiotherapy (CIRT) is more effective for sparing non-tumorous liver. High linear energy transfer...